WRAL Tech Wire

Metabolon's new biomarker technology adds to drug, nutrient testing capabilities

 RTP genomics firm Metabolon lands deal renewal with Syngenta

Metabolon and Syngenta have renewed an agreement through which Metabolon provides biochemical profiling technology to the agribusiness giant.

 RTP firm Metabolon helps set pace in improved diagnostic medical testing

Companies specializing in innovative diagnostics are likely not only to find financial success, but to improve the way health care is delivered to patients. Metabolon is among the merging leaders.

Metabolon’s “Analytical Platform”:

 NC Biotech Center's Industrial Fellowship Program leads to new careers

The North Carolina Biotechnology Center's Industrial Fellowship Program provides opportunities for Ph.D. scientists from the state's many prestigious universities to gain valuable industry-based experience. Metabolon's Meredith Brown is proof.

Meredith Brown

 RTP-based Metabolon sues rival biomarker firm

Stemina Biomarker Discovery Inc. is accused of infringing two patents that cover methods of drug discovery, disease treatment and diagnosis using the study of the chemical processes of metabolites.

 RTP genomics firm Metabolon buys California company

Metabolon adds lipids capabilities in deal for Lipomics Technologies. Its top executive becomes CTO at Metabolon.

 Genomics firm Metabolon receives 19th patent

The Triangle-based firm is awarded a patent for data analysis. It's the company's sixth technology patent.

 Sensus meters under fire; HP woes help Red Hat; Quintiles top Asia CRO; Metabolon accreditation

Bulldog Blog headlines: Sensus' smartmeters are taking criticism in New York; HP's woes are boosting Red Hat Enterprise Linux; Quintiles is named best CRO in Asia; Metabolon receives accreditation from medical group.

 Metabolon opens metabolomics lab in China

The RTP-based life science firm teams with a Chinese university for the new facility.

Metabolon’s “Analytical Platform”:

 Metabolon lands $13.1M in fourth round of venture financing

The Triangle-based company, which focuses on biomarker technology, secures a new investor. Local venture firm Aurora Funds also is an investor.

Metabolon’s “Analytical Platform”:

 Triangle-based Metabolon cracks Fortune potential IPO list

The company focuses on biomarket technology. Its potential personalized medicine potential earns the venture capital-backed firm a spot on list of emerging companies.

 Metabolon secures two more patents for its biomarker technology

The RTP-based life sciences firm is awarded patents for methods of drug discovery and also method for analysis using metabolomics technology.

Metabolon’s “Analytical Platform”:

 Metabolon secures another patent in biomarker technology

The venture capital-backed firm’s technology is based on metabolomics. This is the third patent it has received in 2010.

 Epic Games unveils ‘Project Sword’ at Apple’s media event

Mike Capps, president of the Cary-based videogame developer, took the stage to show off a new action title developed exclusively for iPhones and other mobile devices.

Epic's Citadel on an iPhone

 Metabolon receives patents targeting depression, schizophrenia

RTP-based firm, which landed a broad research patent in January, wins protection for technology to detect biomarkers related to mental disorders.

 RTP-based Metabolon lands ‘substantial’ patent for drug technology

Venture-backed company focuses on biomarkers linked to metabolism. “This issued patent is very substantial in that it covers in a very broad way the use of any metabolomic method to find biomarkers associated with any drug or toxic agent,” says Metabolon CEO John Ryals.

Metabolon’s “Analytical Platform”:

 Metabolon secures two new investors, closes on $6 million in financing